| Company
| InsiderPie Expert Score
| P/E ratio
| Gross margin
| EBIT margin
| ROA
| Net income per employee
|
| Accuray Incorporated
|
50
/ 100
| -6.7
| 30.8%
| -0.3%
| -4.2%
| -€16.67K
|
| Penumbra, Inc.
|
61
/ 100
| 60
| 66.8%
| 13.0%
| 9.4%
| €31.04K
|
| enVVeno Medical Corporation
|
50
/ 100
| -3.6
| 50.0%
| -2,904.6%
| -67.9%
| -€505.58K
|
| Cutera, Inc.
|
47
/ 100
| -0.015
| 15.2%
| -84.7%
| -56.2%
| -€260.85K
|
| Stryker Corporation
|
73
/ 100
| 50
| 63.7%
| 16.1%
| 6.3%
| €47.29K
|
| Heska Corporation
|
49
/ 100
| -71
| 42.9%
| -6.7%
| -3.1%
| -€19.60K
|
| Boston Scientific Corporation
|
66
/ 100
| 69
| 68.3%
| 17.0%
| 6.0%
| €40.25K
|
| Stratec SE
|
53
/ 100
| 18
| 30.3%
| 10.0%
| 3.5%
| €10.06K
|
| Cytosorbents Corporation
|
51
/ 100
| -7
| 72.6%
| -47.6%
| -20.3%
| -€55.72K
|
| Co-Diagnostics, Inc.
|
50
/ 100
| -0.28
| 39.6%
| -3,861.1%
| -77.5%
| -€232.21K
|
| Apollo Endosurgery, Inc.
|
50
/ 100
| -15
| 55.2%
| -36.2%
| -36.1%
| -€167.96K
|
| Insulet Corporation
|
69
/ 100
| 87
| 71.5%
| 17.3%
| 8.1%
| €53.76K
|
| ShockWave Medical, Inc.
|
52
/ 100
| 77
| 87.0%
| 20.7%
| 9.9%
| €94.85K
|
| BICO Group AB (publ)
|
48
/ 100
| -11
| 74.7%
| -80.1%
| -22.5%
| -€270.77K
|
| Getinge AB (publ)
|
51
/ 100
| 310
| 46.9%
| 7.7%
| 2.6%
| €11.92K
|
| Nevro Corp.
|
49
/ 100
| -2
| 65.0%
| -30.0%
| -20.5%
| -€87.91K
|
| IRadimed Corporation
|
45
/ 100
| 36
| 77.1%
| 30.9%
| 18.5%
| €112.76K
|
| Avanos Medical, Inc.
|
48
/ 100
| -1.2
| 51.6%
| -67.1%
| -43.9%
| -€179.32K
|
| Globus Medical, Inc.
|
51
/ 100
| 19
| 62.1%
| 13.3%
| 8.3%
| €68.10K
|
| Inogen, Inc.
|
45
/ 100
| -6.9
| 43.0%
| -9.3%
| -8.3%
| -€28.21K
|
| EKF Diagnostics Holdings plc
|
51
/ 100
| 0.11
| 48.9%
| 13.3%
| 13.2%
| €41.42K
|
| Anika Therapeutics, Inc.
|
45
/ 100
| -4.9
| 83.0%
| 19.9%
| -17.4%
| -€97.69K
|
| Integer Holdings Corporation
|
52
/ 100
| 48
| 26.9%
| 12.1%
| 2.6%
| €6.73K
|
| Alphatec Holdings, Inc.
|
52
/ 100
| -11
| 94.8%
| -18.3%
| -19.7%
| -€152.22K
|
| Cardiovascular Systems, Inc.
|
52
/ 100
| -22
| 72.4%
| -16.1%
| -12.2%
| -€44.48K
|
| Accelerate Diagnostics, Inc.
|
50
/ 100
| -0.017
| 23.1%
| -301.9%
| -175.3%
| -€398.33K
|
| Zimmer Biomet Holdings, Inc.
|
51
/ 100
| 23
| 69.3%
| 16.6%
| 3.4%
| €40.34K
|
| Pulmonx Corporation
|
49
/ 100
| -2.3
| 73.4%
| -64.2%
| -41.0%
| -€166.09K
|
| Delcath Systems, Inc.
|
49
/ 100
| 466
| 116.3%
| 10.0%
| 1.0%
| €10.63K
|
| SI-BONE, Inc.
|
48
/ 100
| -37
| 79.6%
| -13.1%
| -9.3%
| -€53.09K
|
| Episurf Medical AB (publ)
|
50
/ 100
| -1.1
| 14.1%
| -475.6%
| -82.0%
| -€220.04K
|
| Euroapi S.A.
|
47
/ 100
| -0.81
| 15.1%
| -5.7%
| -28.5%
| -€129.15K
|
| aap Implantate AG
|
50
/ 100
| -5.5
| 86.8%
| 38.1%
| -22.9%
| -€41.71K
|
| Carmat SA
|
50
/ 100
| -0.44
| -524.9%
| -1,489.3%
| -248.3%
| -€650.28K
|
| CellaVision AB (publ)
|
50
/ 100
| 30
| 69.1%
| 26.5%
| 14.1%
| €62.82K
|
| CONMED Corporation
|
52
/ 100
| 28
| 54.3%
| 8.8%
| 2.8%
| €13.99K
|
| Abbott Laboratories
|
51
/ 100
| 17
| 56.1%
| 17.6%
| 16.6%
| €104.42K
|
| Inspire Medical Systems, Inc.
|
55
/ 100
| 88
| 84.9%
| 4.2%
| 5.5%
| €30.45K
|
| Cytek Biosciences, Inc.
|
51
/ 100
| -33
| 53.5%
| -16.2%
| -2.6%
| -€16.47K
|
| Eckert & Ziegler Strahlen- und Medizintechnik AG
|
54
/ 100
| 38
| 48.0%
| 21.4%
| 8.3%
| €33.77K
|
| Glaukos Corporation
|
51
/ 100
| -65
| 76.9%
| -18.8%
| -8.8%
| -€74.99K
|
| Senseonics Holdings, Inc.
|
50
/ 100
| -6.1
| 41.6%
| -199.2%
| -46.3%
| -€471.25K
|
| OrthoPediatrics Corp.
|
53
/ 100
| -12
| 71.7%
| -14.1%
| -9.2%
| -€69.12K
|
| Abiomed, Inc.
|
52
/ 100
| 65
| 81.3%
| 23.6%
| 15.7%
| €113.42K
|
| Sientra, Inc.
|
47
/ 100
| -0.035
| 42.1%
| -57.1%
| -42.5%
| -€166.79K
|
| Boule Diagnostics AB (publ)
|
50
/ 100
| -43
| 42.9%
| 2.8%
| -1.6%
| -€3.50K
|
| ZimVie Inc.
|
50
/ 100
| -14
| 65.3%
| -2.1%
| -2.6%
| -€9.37K
|
| Tactile Systems Technology, Inc.
|
47
/ 100
| 13
| 70.9%
| 7.4%
| 7.0%
| €14.92K
|
| Surmodics, Inc.
|
50
/ 100
| -24
| 73.1%
| -10.2%
| -10.4%
| -€38.59K
|
| CYBERDYNE Inc.
|
50
/ 100
| -69
| 50.0%
| -37.1%
| -0.7%
| -€7.99K
|
| Cerus Corporation
|
50
/ 100
| -17
| 55.2%
| -4.8%
| -7.4%
| -€22.14K
|
| Edwards Lifesciences Corporation
|
57
/ 100
| 32
| 78.3%
| 26.8%
| 10.3%
| €73.73K
|
| Geratherm Medical AG
|
50
/ 100
| 10
| 41.7%
| 2.1%
| 6.4%
| €9.79K
|
| Beyond Air, Inc.
|
50
/ 100
| -0.47
| -6.7%
| -575.7%
| -118.5%
| -€292.08K
|
| Ambu A/S
|
52
/ 100
| 470
| 59.9%
| 13.2%
| 4.9%
| €9.61K
|
| Smith & Nephew plc
|
51
/ 100
| 0.25
| 70.0%
| 12.4%
| 6.6%
| €34.74K
|
| Circassia Group Plc
|
53
/ 100
| 21
| 69.5%
| 15.6%
| 19.3%
| €136.99K
|
| Apyx Medical Corporation
|
49
/ 100
| -4.6
| 62.6%
| -19.8%
| -25.3%
| -€56.29K
|
| Nemaura Medical Inc.
|
50
/ 100
| -0.00064
| 295.2%
| 625.2%
| -121.8%
| -€148.96K
|
| Xtant Medical Holdings, Inc.
|
50
/ 100
| 53
| 62.0%
| 4.8%
| 1.6%
| €6.87K
|
| Semler Scientific, Inc.
|
49
/ 100
| 7.3
| 90.8%
| -94.7%
| 8.1%
| €521.11K
|
| Senzime AB (publ)
|
50
/ 100
| -5.9
| 40.7%
| -122.6%
| -29.3%
| -€211.31K
|
| Varex Imaging Corporation
|
50
/ 100
| -2.7
| 34.1%
| -4.4%
| -12.3%
| -€49.06K
|
| iRhythm Technologies, Inc.
|
46
/ 100
| -92
| 70.4%
| -9.1%
| -5.2%
| -€21.91K
|
| STRATA Skin Sciences, Inc.
|
49
/ 100
| -0.88
| 57.8%
| -33.3%
| -35.9%
| -€88.70K
|
| EL.En. S.p.A.
|
50
/ 100
| 28
| 44.4%
| 14.6%
| 4.4%
| €14.93K
|
| GN Store Nord A/S
|
51
/ 100
| 105
| 54.6%
| 10.3%
| 3.0%
| €16.02K
|
| DexCom, Inc.
|
69
/ 100
| 45
| 59.0%
| 17.2%
| 9.6%
| €60.17K
|
| Integra LifeSciences Holdings Corporation
|
49
/ 100
| -2
| 52.2%
| 3.7%
| -13.6%
| -€95.96K
|
| Demant A/S
|
51
/ 100
| 78
| 75.7%
| 18.5%
| 14.5%
| €31.72K
|
| Sintx Technologies, Inc.
|
50
/ 100
| -0.58
| 41.8%
| -728.6%
| -136.4%
| -€534.15K
|
| Polarean Imaging plc
|
50
/ 100
| -0.015
| 7.2%
| -412.5%
| -160.8%
| -€523.86K
|
| Tandem Diabetes Care, Inc.
|
49
/ 100
| -7.1
| 53.2%
| -19.2%
| -23.3%
| -€65.36K
|
| NanoVibronix, Inc.
|
50
/ 100
| -0.62
| 32.1%
| -349.2%
| -9.9%
| -€139.56K
|
| Koninklijke Philips N.V.
|
53
/ 100
| 116
| 43.5%
| 6.1%
| 0.6%
| €2.45K
|
| Align Technology, Inc.
|
52
/ 100
| 36
| 68.4%
| 13.4%
| 6.1%
| €15.20K
|
| Drägerwerk AG & Co. KGaA
|
50
/ 100
| 9.8
| 45.4%
| 5.2%
| 4.0%
| €7.83K
|
| Medacta Group SA
|
48
/ 100
| 21
| 67.8%
| 16.5%
| 17.6%
| €79.26K
|
| Guerbet SA
|
50
/ 100
| 6.6
| 40.8%
| 5.2%
| 4.0%
| €14.58K
|
| Venus Concept Inc.
|
47
/ 100
| -0.066
| 64.4%
| -59.0%
| -88.6%
| -€159.29K
|
| Pacific Biosciences of California, Inc.
|
47
/ 100
| -0.69
| 25.4%
| -412.5%
| -62.7%
| -€745.94K
|
| Ion Beam Applications SA
|
50
/ 100
| 14
| 32.5%
| 4.9%
| 4.0%
| €12.79K
|
| NuVasive, Inc.
|
49
/ 100
| 74
| 71.7%
| 6.7%
| 1.4%
| €8.08K
|
| Sonova Holding AG
|
52
/ 100
| 13
| 71.8%
| 18.3%
| 19.3%
| €66.32K
|
| Novacyt S.A.
|
50
/ 100
| -0.77
| -32.0%
| -158.8%
| -38.5%
| -€188.46K
|
| InspireMD, Inc.
|
51
/ 100
| -8.7
| 24.9%
| -602.9%
| -11.0%
| -€86.86K
|
| Asensus Surgical, Inc.
|
50
/ 100
| -1.1
| -33.9%
| -786.5%
| -217.6%
| -€344.77K
|
| ViewRay, Inc.
|
48
/ 100
| -0.04
| 8.0%
| -101.5%
| -49.0%
| -€329.61K
|
| GBS Inc.
|
50
/ 100
| -0.04
| 43.1%
| -331.7%
| -108.2%
| -€771.17K
|
| Axonics, Inc.
|
52
/ 100
| -643
| 75.5%
| -3.4%
| -0.7%
| -€6.05K
|
| Artivion, Inc.
|
50
/ 100
| -136
| 64.5%
| 6.1%
| -1.1%
| -€6.49K
|
| NeuroMetrix, Inc.
|
50
/ 100
| -1.2
| 55.4%
| -289.6%
| -50.9%
| -€511.38K
|
| Myomo, Inc.
|
50
/ 100
| -8.6
| 66.6%
| -28.5%
| -35.3%
| -€55.63K
|
| MaxCyte, Inc.
|
48
/ 100
| -5.4
| 80.0%
| -142.2%
| -21.4%
| -€340.89K
|
| Deltex Medical Group plc
|
50
/ 100
| -0.0029
| 66.8%
| -49.0%
| -42.0%
| -€110.97K
|
| Bio-Rad Laboratories, Inc.
|
50
/ 100
| -8.5
| 52.3%
| 8.9%
| -7.6%
| -€81.83K
|
| Ikonisys S.A.
|
49
/ 100
| -4
| 23.2%
| -371.0%
| -20.1%
| -€550.76K
|
| Medartis Holding AG
|
46
/ 100
| 266
| 79.8%
| 2.8%
| 0.8%
| €4.68K
|
| Siemens Healthineers AG
|
54
/ 100
| 20
| 38.8%
| 13.8%
| 4.9%
| €30.17K
|
| SeaSpine Holdings Corporation
|
52
/ 100
| 0
| 60.0%
| -28.8%
| -17.3%
| -€105.58K
|
